Prosecution Insights
Prosecution Insights
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (40%) |
| §112 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, HA S | 1 | 58.4% | -21.6% |
| KASAYAN, KATRIEL BARCELLANO | 1 | 33.3% | +0.0% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 47.6% | +50.0% |
| AEDER, SEAN E | 1 | 56.9% | +19.9% |
| GOLDBERG, JEANINE ANNE | 1 | 45.9% | +40.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18564850 | POLYTHIOPHENE COMPOUND AND CONDUCTIVE MATERIAL COMPOSITION | NGUYEN, HA S | — |
| 18561249 | METHOD OF PRODUCING BRAIN MICROVASCULAR ENDOTHELIAL-LIKE CELLS AND USE THEREOF | KASAYAN, KATRIEL BARCELLANO | — |
| 18036733 | METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DETERMINING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR COLLECTING DATA FOR USE IN DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DIAGNOSING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, IN VITRO METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, ... | BUCHANAN, BAILEY CHEYENNE | — |
| 17630693 | ESOPHAGEAL CANCER BIOMARKER AND USE THEREFOR | GOLDBERG, JEANINE ANNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17789867 | METHOD FOR DETECTING INDICATOR OF T-CELL LYMPHOMA AND UTILIZATION THEREOF | AEDER, SEAN E | 71d |
| 18036733 | METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DETERMINING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR COLLECTING DATA FOR USE IN DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DIAGNOSING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, IN VITRO METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, ... | BUCHANAN, BAILEY CHEYENNE | — |
| 17630693 | ESOPHAGEAL CANCER BIOMARKER AND USE THEREFOR | GOLDBERG, JEANINE ANNE | — |
| Art Unit | Apps |
|---|---|
| 1682 | 2 |
| 1634 | 1 |
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18564850 | POLYTHIOPHENE COMPOUND AND CONDUCTIVE MATERIAL COMPOSITION | NGUYEN, HA S | — | §102§112Other | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18561249 | METHOD OF PRODUCING BRAIN MICROVASCULAR ENDOTHELIAL-LIKE CELLS AND USE THEREOF | KASAYAN, KATRIEL BARCELLANO | 1634 | §103§112 | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18036733 | METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DETERMINING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR COLLECTING DATA FOR USE IN DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DIAGNOSING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, IN VITRO METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, ... | BUCHANAN, BAILEY CHEYENNE | 1682 | §101§102§112 | Final Rejection | — | Pending | May 12, 2023 |
| 17789867 | METHOD FOR DETECTING INDICATOR OF T-CELL LYMPHOMA AND UTILIZATION THEREOF | AEDER, SEAN E | 1642 | §112 | Final Rejection | 71d | Pending | Jun 29, 2022 |
| 17630693 | ESOPHAGEAL CANCER BIOMARKER AND USE THEREFOR | GOLDBERG, JEANINE ANNE | 1682 | §101§102§112 | Non-Final OA | — | Pending | Jan 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial